{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 537, "items": [{"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T19:32:06Z", "timestamp": 1574364726462}, "reference-count": 0, "publisher": "Bentham Science Publishers Ltd.", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["PRA"], "published-print": {"date-parts": [[2007, 6, 1]]}, "DOI": "10.2174/157489207780832478", "type": "journal-article", "created": {"date-parts": [[2008, 4, 18]], "date-time": "2008-04-18T01:24:50Z", "timestamp": 1208481890000}, "page": "167-174", "source": "Crossref", "is-referenced-by-count": 38, "title": ["Thalidomide Analogues as Anticancer Drugs"], "prefix": "10.2174", "volume": "2", "author": [{"family": "Jeanny B. Aragon-Ching", "sequence": "first", "affiliation": []}, {"family": "Haiqing Li", "sequence": "additional", "affiliation": []}, {"family": "Erin R. Gardner", "sequence": "additional", "affiliation": []}, {"family": "William D. Figg", "sequence": "additional", "affiliation": [{"name": "Medical Oncology Branch,CCR, NCI/NIH, 9000 Rockville Pike, Building 10, Room 5A01, Rockville,Maryland 20892, USA."}]}], "member": "965", "container-title": ["Recent Patents on Anti-Cancer Drug Discovery"], "language": "en", "link": [{"URL": "http://eurekaselect.com/article/download/78322", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 7, 12]], "date-time": "2017-07-12T07:54:21Z", "timestamp": 1499846061000}, "score": 40.405113, "issued": {"date-parts": [[2007, 6, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2007, 6, 1]]}, "issue": "2"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/157489207780832478", "ISSN": ["1574-8928"], "issn-type": [{"value": "1574-8928", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T15:01:16Z", "timestamp": 1574694076931}, "reference-count": 96, "publisher": "Informa Healthcare", "issue": "8", "content-domain": {"domain": ["www.tandfonline.com"], "crossmark-restriction": true}, "short-container-title": ["Expert Opinion on Investigational Drugs"], "published-print": {"date-parts": [[2015, 8, 3]]}, "DOI": "10.1517/13543784.2015.1048333", "type": "journal-article", "created": {"date-parts": [[2015, 5, 18]], "date-time": "2015-05-18T11:36:57Z", "timestamp": 1431949017000}, "page": "1059-1073", "update-policy": "http://dx.doi.org/10.1080/tandf_crossmark_01", "source": "Crossref", "is-referenced-by-count": 5, "title": ["A synopsis of drugs currently in preclinical and early clinical development for the treatment of benign prostatic hyperplasia"], "prefix": "10.1517", "volume": "24", "author": [{"given": "Kanika", "family": "Gupta", "sequence": "first", "affiliation": []}, {"given": "Mona", "family": "Yezdani", "sequence": "additional", "affiliation": []}, {"given": "Tiffany", "family": "Sotelo", "sequence": "additional", "affiliation": []}, {"given": "Jeanny B", "family": "Aragon-Ching", "sequence": "additional", "affiliation": []}], "member": "3197", "published-online": {"date-parts": [[2015, 5, 18]]}, "reference": [{"key": "CIT0001", "DOI": "10.1016/j.juro.2011.01.074", "doi-asserted-by": "publisher"}, {"key": "CIT0002", "DOI": "10.1002/nau.10052", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "DOI": "10.1111/j.1464-410X.2009.08369.x", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "DOI": "10.1016/j.eururo.2013.03.004", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "DOI": "10.1097/MOU.0000000000000007", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "DOI": "10.1016/j.purol.2014.12.003", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "DOI": "10.1016/j.juro.2006.06.004", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "DOI": "10.1111/j.1743-6109.2008.00779.x", "doi-asserted-by": "publisher"}, {"key": "CIT0009", "DOI": "10.1111/j.1442-2042.2006.01535.x", "doi-asserted-by": "publisher"}, {"key": "CIT0010", "author": "Lepor H", "volume": "148", "first-page": "1467", "year": "1992", "journal-title": "J Urol", "DOI": "10.1016/S0022-5347(17)36941-0", "doi-asserted-by": "crossref"}, {"key": "CIT0011", "DOI": "10.1517/14740338.2014.936376", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.1345/aph.1K679", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "DOI": "10.1016/S0090-4295(98)00126-5", "doi-asserted-by": "publisher"}, {"key": "CIT0014", "DOI": "10.1097/MOU.0b013e32834d9bfd", "doi-asserted-by": "publisher"}, {"key": "CIT0015", "DOI": "10.1016/S0022-5347(01)62386-3", "doi-asserted-by": "publisher"}, {"key": "CIT0016", "DOI": "10.1016/j.eururo.2014.10.016", "doi-asserted-by": "publisher"}, {"key": "CIT0017", "DOI": "10.1016/j.eururo.2014.07.013", "doi-asserted-by": "publisher"}, {"key": "CIT0018", "DOI": "10.1016/j.ijpharm.2013.06.065", "doi-asserted-by": "publisher"}, {"key": "CIT0019", "DOI": "10.1046/j.1464-410X.2003.04309.x", "doi-asserted-by": "publisher"}, {"key": "CIT0020", "DOI": "10.1517/14656566.2012.714368", "doi-asserted-by": "publisher"}, {"key": "CIT0021", "DOI": "10.4103/0253-7613.144935", "doi-asserted-by": "publisher"}, {"key": "CIT0022", "DOI": "10.1097/MOU.0000000000000120", "doi-asserted-by": "publisher"}, {"key": "CIT0023", "author": "Novara G", "volume": "114", "first-page": "427", "year": "2014", "journal-title": "BJU Int"}, {"key": "CIT0024", "author": "Novara G", "year": "2014", "journal-title": "BJU Int"}, {"key": "CIT0025", "DOI": "10.1111/ijcp.12135", "doi-asserted-by": "publisher"}, {"key": "CIT0026", "DOI": "10.1111/jsm.12525", "doi-asserted-by": "publisher"}, {"key": "CIT0027", "DOI": "10.1016/j.urology.2013.02.020", "doi-asserted-by": "publisher"}, {"key": "CIT0028", "author": "Huang JJ", "volume": "69", "first-page": "578", "year": "2014", "journal-title": "Pharmazie"}, {"key": "CIT0029", "DOI": "10.1210/jc.2006-2203", "doi-asserted-by": "publisher"}, {"key": "CIT0030", "DOI": "10.1056/NEJM199210223271701", "doi-asserted-by": "publisher"}, {"key": "CIT0031", "author": "Stoner E", "volume": "147", "first-page": "1298", "year": "1992", "journal-title": "J Urol", "DOI": "10.1016/S0022-5347(17)37547-X", "doi-asserted-by": "crossref"}, {"key": "CIT0032", "DOI": "10.1016/S0090-4295(98)00567-6", "doi-asserted-by": "publisher"}, {"key": "CIT0033", "DOI": "10.1007/s00345-009-0493-y", "doi-asserted-by": "publisher"}, {"key": "CIT0034", "DOI": "10.1007/s00345-010-0507-9", "doi-asserted-by": "publisher"}, {"key": "CIT0035", "DOI": "10.1111/j.1743-6109.2012.02759.x", "doi-asserted-by": "publisher"}, {"key": "CIT0036", "DOI": "10.1111/j.1743-6109.2011.02425.x", "doi-asserted-by": "publisher"}, {"key": "CIT0037", "DOI": "10.1097/01.ju.0000136430.37245.b9", "doi-asserted-by": "publisher"}, {"key": "CIT0038", "author": "Tacklind J", "issue": "10", "first-page": "CD006015", "year": "2010", "journal-title": "Cochrane Database Syst Rev"}, {"key": "CIT0039", "DOI": "10.1016/S0090-4295(02)01905-2", "doi-asserted-by": "publisher"}, {"issue": "9", "key": "CIT0040", "first-page": "S22", "volume": "6", "author": "Roehrborn CG", "year": "2004", "journal-title": "Rev Urol"}, {"key": "CIT0041", "DOI": "10.1136/bmj.f2109", "doi-asserted-by": "publisher"}, {"key": "CIT0042", "DOI": "10.1111/j.1464-410X.2011.10195.x", "doi-asserted-by": "publisher"}, {"key": "CIT0043", "DOI": "10.1056/NEJMoa030660", "doi-asserted-by": "publisher"}, {"key": "CIT0044", "DOI": "10.1016/j.urology.2008.09.079", "doi-asserted-by": "publisher"}, {"key": "CIT0045", "DOI": "10.1056/NEJMoa1215932", "doi-asserted-by": "publisher"}, {"key": "CIT0046", "DOI": "10.1056/NEJMoa0908127", "doi-asserted-by": "publisher"}, {"key": "CIT0047", "DOI": "10.1016/j.urology.2014.04.016", "doi-asserted-by": "publisher"}, {"key": "CIT0048", "DOI": "10.1158/1940-6207.CAPR-08-0092", "doi-asserted-by": "publisher"}, {"key": "CIT0049", "author": "Klotz L", "volume": "1", "first-page": "17", "year": "2007", "journal-title": "Can Urol Assoc J"}, {"key": "CIT0050", "DOI": "10.1056/NEJMp1106783", "doi-asserted-by": "publisher"}, {"key": "CIT0051", "DOI": "10.1016/j.biochi.2013.07.023", "doi-asserted-by": "publisher"}, {"key": "CIT0052", "DOI": "10.1056/NEJMoa030656", "doi-asserted-by": "publisher"}, {"key": "CIT0053", "DOI": "10.1097/MOU.0b013e3283336f96", "doi-asserted-by": "publisher"}, {"key": "CIT0054", "DOI": "10.1016/j.eururo.2009.09.035", "doi-asserted-by": "publisher"}, {"key": "CIT0055", "author": "Roehrborn CG", "year": "2015", "journal-title": "BJU Int"}, {"key": "CIT0056", "DOI": "10.1016/j.juro.2006.10.055", "doi-asserted-by": "publisher"}, {"key": "CIT0057", "DOI": "10.1016/j.juro.2013.10.074", "doi-asserted-by": "publisher"}, {"key": "CIT0058", "DOI": "10.1016/j.juro.2008.06.079", "doi-asserted-by": "publisher"}, {"key": "CIT0059", "DOI": "10.1016/j.eururo.2008.01.075", "doi-asserted-by": "publisher"}, {"key": "CIT0060", "DOI": "10.5527/wjn.v4.i1.138", "doi-asserted-by": "publisher"}, {"key": "CIT0061", "DOI": "10.1002/pros.22686", "doi-asserted-by": "publisher"}, {"key": "CIT0062", "DOI": "10.1111/j.1743-6109.2011.02416.x", "doi-asserted-by": "publisher"}, {"key": "CIT0063", "DOI": "10.1002/nau.22517", "doi-asserted-by": "publisher"}, {"key": "CIT0064", "DOI": "10.1016/j.eururo.2012.02.033", "doi-asserted-by": "publisher"}, {"key": "CIT0065", "DOI": "10.1016/j.eururo.2012.01.013", "doi-asserted-by": "publisher"}, {"key": "CIT0066", "DOI": "10.1111/j.1464-410X.2009.08822.x", "doi-asserted-by": "publisher"}, {"key": "CIT0067", "author": "Lee DS", "volume": "93", "first-page": "84", "year": "2014", "journal-title": "Urol Int", "DOI": "10.1159/000355360", "doi-asserted-by": "crossref"}, {"key": "CIT0068", "DOI": "10.1111/j.1464-410X.2006.06105.x", "doi-asserted-by": "publisher"}, {"key": "CIT0069", "DOI": "10.1016/j.juro.2013.09.059", "doi-asserted-by": "publisher"}, {"key": "CIT0070", "DOI": "10.1056/NEJM199104253241707", "doi-asserted-by": "publisher"}, {"key": "CIT0071", "DOI": "10.1016/S0090-4295(03)00477-1", "doi-asserted-by": "publisher"}, {"key": "CIT0072", "DOI": "10.1016/j.juro.2011.04.062", "doi-asserted-by": "publisher"}, {"key": "CIT0073", "DOI": "10.1016/j.eururo.2012.10.005", "doi-asserted-by": "publisher"}, {"key": "CIT0074", "DOI": "10.1016/j.juro.2014.02.004", "doi-asserted-by": "publisher"}, {"key": "CIT0075", "author": "Tacklind J", "issue": "2", "first-page": "CD001423", "year": "2009", "journal-title": "Cochrane Database Syst Rev"}, {"key": "CIT0076", "DOI": "10.1001/jama.2011.1364", "doi-asserted-by": "publisher"}, {"key": "CIT0077", "DOI": "10.1111/j.1464-410X.2012.11172.x", "doi-asserted-by": "publisher"}, {"key": "CIT0078", "author": "Tacklind J", "volume": "12", "first-page": "CD001423", "year": "2012", "journal-title": "Cochrane Database Syst Rev"}, {"key": "CIT0079", "DOI": "10.1016/j.ctim.2013.01.007", "doi-asserted-by": "publisher"}, {"key": "CIT0080", "author": "Bosch RJ", "volume": "141", "first-page": "68", "year": "1989", "journal-title": "J Urol", "DOI": "10.1016/S0022-5347(17)40591-X", "doi-asserted-by": "crossref"}, {"key": "CIT0081", "DOI": "10.1111/j.1464-410X.2012.11107.x", "doi-asserted-by": "publisher"}, {"key": "CIT0082", "DOI": "10.1016/j.eururo.2008.03.069", "doi-asserted-by": "publisher"}, {"key": "CIT0083", "DOI": "10.1016/j.eururo.2010.11.024", "doi-asserted-by": "publisher"}, {"key": "CIT0084", "DOI": "10.1016/j.juro.2012.11.003", "doi-asserted-by": "publisher"}, {"key": "CIT0086", "DOI": "10.2147/TCRM.S13883", "doi-asserted-by": "publisher"}, {"key": "CIT0087", "DOI": "10.1159/000315994", "doi-asserted-by": "publisher"}, {"key": "CIT0088", "author": "Garimella PS", "issue": "4", "first-page": "CD007360", "year": "2009", "journal-title": "Cochrane Database Syst Rev"}, {"key": "CIT0089", "DOI": "10.1185/03007995.2013.861813", "doi-asserted-by": "publisher"}, {"key": "CIT0090", "DOI": "10.1002/pros.22930", "doi-asserted-by": "publisher"}, {"key": "CIT0091", "DOI": "10.1093/carcin/bgg197", "doi-asserted-by": "publisher"}, {"key": "CIT0092", "DOI": "10.1002/pros.22924", "doi-asserted-by": "publisher"}, {"key": "CIT0093", "DOI": "10.1177/2040622311423128", "doi-asserted-by": "publisher"}, {"key": "CIT0094", "author": "Kunit T", "volume": "6", "first-page": "67", "year": "2014", "journal-title": "Res Rep Urol"}, {"key": "CIT0096", "DOI": "10.1517/13543784.2013.761973", "doi-asserted-by": "publisher"}, {"key": "CIT0097", "DOI": "10.1111/j.1365-2605.2009.00972.x", "doi-asserted-by": "publisher"}, {"key": "CIT0098", "DOI": "10.1002/pros.22951", "doi-asserted-by": "publisher"}], "container-title": ["Expert Opinion on Investigational Drugs"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1517/13543784.2015.1048333", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 25]], "date-time": "2019-08-25T07:08:52Z", "timestamp": 1566716932000}, "score": 23.24635, "issued": {"date-parts": [[2015, 5, 18]]}, "references-count": 96, "journal-issue": {"published-online": {"date-parts": [[2015, 6, 12]]}, "published-print": {"date-parts": [[2015, 8, 3]]}, "issue": "8"}, "alternative-id": ["10.1517/13543784.2015.1048333"], "URL": "http://dx.doi.org/10.1517/13543784.2015.1048333", "relation": {"cites": []}, "ISSN": ["1354-3784", "1744-7658"], "issn-type": [{"value": "1354-3784", "type": "print"}, {"value": "1744-7658", "type": "electronic"}], "assertion": [{"value": "The publishing and review policy for this title is described in its Aims & Scope.", "order": 1, "name": "peerreview_statement", "label": "Peer Review Statement"}, {"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ieid20", "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ieid20", "order": 2, "name": "aims_and_scope_url", "label": "Aim & Scope"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T09:25:18Z", "timestamp": 1575192318585}, "publisher-location": "2455 Teller Road,\u00a0 Thousand Oaks\u00a0 California\u00a0 91320\u00a0 United States\u00a0", "reference-count": 0, "publisher": "SAGE Publications, Inc.", "isbn-type": [{"value": "9781412904759", "type": "print"}, {"value": "9781412952484", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.4135/9781412952484.n610", "type": "reference-entry", "created": {"date-parts": [[2013, 2, 25]], "date-time": "2013-02-25T18:43:03Z", "timestamp": 1361817783000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Thalidomide"], "prefix": "10.4135", "author": [{"given": "Lai-Ming", "family": "Ching", "sequence": "first", "affiliation": []}], "member": "179", "container-title": ["Encyclopedia of Human Development"], "deposited": {"date-parts": [[2015, 11, 20]], "date-time": "2015-11-20T21:28:58Z", "timestamp": 1448054938000}, "score": 22.146366, "issued": {"date-parts": [[null]]}, "ISBN": ["9781412904759", "9781412952484"], "references-count": 0, "alternative-id": ["10.4135/9781412952484"], "URL": "http://dx.doi.org/10.4135/9781412952484.n610"}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T17:02:42Z", "timestamp": 1575478962553}, "reference-count": 0, "publisher": "Medwin Publishers", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["ACT"], "DOI": "10.23880/act-16000143", "type": "journal-article", "created": {"date-parts": [[2019, 7, 18]], "date-time": "2019-07-18T12:36:44Z", "timestamp": 1563453404000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Idiosyncratic Reactions: Drugs Induced Steven Johnson's Syndrome"], "prefix": "10.23880", "volume": "3", "author": [{"given": "Medani", "family": "AB", "sequence": "first", "affiliation": []}], "member": "9969", "published-online": {"date-parts": [[2016]]}, "container-title": ["Advances in Clinical Toxicology"], "original-title": ["Idiosyncratic Reactions: Drugs Induced Steven Johnson's Syndrome"], "deposited": {"date-parts": [[2019, 7, 18]], "date-time": "2019-07-18T12:36:46Z", "timestamp": 1563453406000}, "score": 21.14505, "issued": {"date-parts": [[2016]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.23880/act-16000143", "ISSN": ["2577-4328"], "issn-type": [{"value": "2577-4328", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:03:54Z", "timestamp": 1574489034943}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1998, 8, 1]], "date-time": "1998-08-01T00:00:00Z", "timestamp": 901929600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[1998, 8]]}, "DOI": "10.1038/bjc.1998.495", "type": "journal-article", "created": {"date-parts": [[2011, 1, 14]], "date-time": "2011-01-14T12:00:31Z", "timestamp": 1295006431000}, "page": "336-343", "source": "Crossref", "is-referenced-by-count": 28, "title": ["Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity"], "prefix": "10.1038", "volume": "78", "author": [{"given": "LM", "family": "Ching", "sequence": "first", "affiliation": []}, {"given": "WL", "family": "Browne", "sequence": "additional", "affiliation": []}, {"given": "R", "family": "Tchernegovski", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Gregory", "sequence": "additional", "affiliation": []}, {"given": "BC", "family": "Baguley", "sequence": "additional", "affiliation": []}, {"given": "BD", "family": "Palmer", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/bjc1998495.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1998495", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1998495.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T16:54:31Z", "timestamp": 1552755271000}, "score": 20.763536, "issued": {"date-parts": [[1998, 8]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1998, 8]]}, "issue": "3"}, "alternative-id": ["BFbjc1998495"], "URL": "http://dx.doi.org/10.1038/bjc.1998.495", "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T10:15:47Z", "timestamp": 1575368147004}, "reference-count": 53, "publisher": "MDPI AG", "issue": "12", "license": [{"URL": "https://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2018, 12, 13]], "date-time": "2018-12-13T00:00:00Z", "timestamp": 1544659200000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Nanomaterials"], "abstract": "<jats:p>The compound 5\u2019-deoxy-5-fluorouridine (5\u2019-DFUR) is a prodrug of the anti-tumor drug 5-fluorouracil (5-FU). Thymidine phosphorylase (TP) is an enzyme that can convert 5\u2019-DFUR to its active form 5-FU and the expression of TP is upregulated in various cancer cells. In this study, 5\u2019-DFUR associated with amphiphilic copolymer poly(\u03b5-caprolactone)-methoxy poly(ethylene glycol) (5\u2019-DFUR-PCL-MPEG) was synthesized, characterized, and self-assembled into functional polymeric micelles. To demonstrate that the prodrug 5\u2019-DFUR could convert into cytotoxic 5-fluorouracil (5-FU) by endogenous TP, HT-29 colorectal cancer cells were treated with 5\u2019-DFUR-PCL-MPEG polymeric micelles for various time periods. Chemotherapeutic drugs doxorubicin (DOX) and 7-ethyl-10-hydroxycamptothecin (SN-38) were also encapsulated separately into 5\u2019-DFUR-PCL-MPEG polymeric micelles to create a dual drug-loaded system. HT-29 cells were treated with DOX or SN-38 encapsulated 5\u2019-DFUR-PCL-MPEG polymeric micelles to examine the efficacy of dual drug-loaded micelles. As a result, HT-29 cells treated with 5\u2019-DFUR-PCL-MPEG polymeric micelles showed up to 40% cell death rate after a 72-h treatment. In contrast, HT-29 cells challenged with DOX or SN-38 encapsulated 5\u2019-DFUR-incorporated polymeric micelles showed 36% and 31% in cell viability after a 72-h treatment, respectively.</jats:p>", "DOI": "10.3390/nano8121041", "type": "journal-article", "created": {"date-parts": [[2018, 12, 14]], "date-time": "2018-12-14T08:58:17Z", "timestamp": 1544777897000}, "page": "1041", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Enhanced Anticancer Activity of 5\u2019-DFUR-PCL-MPEG Polymeric Prodrug Micelles Encapsulating Chemotherapeutic Drugs"], "prefix": "10.3390", "volume": "8", "author": [{"given": "Alicia", "family": "Sawdon", "sequence": "first", "affiliation": []}, {"given": "Jun", "family": "Zhang", "sequence": "additional", "affiliation": []}, {"given": "Xutu", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "Ching-An", "family": "Peng", "sequence": "additional", "affiliation": []}], "member": "1968", "published-online": {"date-parts": [[2018, 12, 13]]}, "reference": [{"key": "ref1", "DOI": "10.1016/S0959-8049(97)00364-X", "doi-asserted-by": "publisher"}, {"key": "ref2", "DOI": "10.3904/kjim.2006.21.1.43", "doi-asserted-by": "publisher"}, {"key": "ref3", "DOI": "10.1093/annonc/mdu055", "doi-asserted-by": "publisher"}, {"key": "ref4", "DOI": "10.1177/1758835918780140", "doi-asserted-by": "publisher"}, {"key": "ref5", "DOI": "10.3390/cancers2031717", "doi-asserted-by": "publisher"}, {"key": "ref6", "DOI": "10.1016/S0968-0896(00)00087-0", "doi-asserted-by": "publisher"}, {"key": "ref7", "DOI": "10.1002/med.20159", "doi-asserted-by": "publisher"}, {"key": "ref8", "first-page": "245", "article-title": "The enzymatic synthesis of nucleosides. I. Thymidine phosphorylase in mammalian tissue", "volume": "207", "author": "Friedkin", "year": "1954", "journal-title": "J. Biol. Chem."}, {"key": "ref9", "DOI": "10.1021/bi00515a048", "doi-asserted-by": "publisher"}, {"key": "ref10", "DOI": "10.1016/0959-8049(96)00061-5", "doi-asserted-by": "publisher"}, {"key": "ref11", "DOI": "10.1111/j.1349-7006.2004.tb02193.x", "doi-asserted-by": "publisher"}, {"key": "ref12", "DOI": "10.1016/j.ejca.2004.02.019", "doi-asserted-by": "publisher"}, {"key": "ref13", "DOI": "10.1038/bjc.1995.392", "doi-asserted-by": "publisher"}, {"key": "ref14", "first-page": "5680", "article-title": "Sensitivity of human KB cells expressing platelet-derived endothelial cell growth factor to pyrimidine antimetabolites", "volume": "53", "author": "Haraguchi", "year": "1993", "journal-title": "Cancer Res."}, {"key": "ref15", "first-page": "746", "article-title": "[Clinical effect of 5\u2032-deoxy-5-fluorouridine (5\u2032-DFUR)]", "volume": "31", "author": "Nakano", "year": "1985", "journal-title": "Gan No Rinsho"}, {"key": "ref16", "first-page": "83", "article-title": "[Effectiveness of high-dose, intermittent 5\u2032-DFUR therapy for advanced gastric cancer]", "volume": "28", "author": "Sumimoto", "year": "2001", "journal-title": "Gan To Kagaku Ryoho"}, {"key": "ref17", "first-page": "1063", "article-title": "[A case of recurrent colon cancer treated markedly effective with 5\u2032-DFUR]", "volume": "20", "author": "Hirano", "year": "1993", "journal-title": "Gan To Kagaku Ryoho"}, {"key": "ref18", "first-page": "2155", "article-title": "[Docetaxel (TXT), epirubicin (EPI) and doxifluridine (5\u2032-DFUR) combination neoadjuvant chemotherapy for outpatients with locally advanced breast cancer]", "volume": "31", "author": "Tagaya", "year": "2004", "journal-title": "Gan To Kagaku Ryoho"}, {"key": "ref19", "first-page": "973", "article-title": "[The efficacy of combination chemotherapy of 5\u2032-deoxy-5-fluorouridine (5\u2032-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients]", "volume": "28", "author": "Iba", "year": "2001", "journal-title": "Gan To Kagaku Ryoho"}, {"key": "ref20", "first-page": "631", "article-title": "[A comparative study with 5\u2032-DFUR alone or in combination with tamoxifen (TAM) or medroxyprogesterone acetate (MPA) for advanced or recurrent breast cancer]", "volume": "19", "author": "Takatsuka", "year": "1992", "journal-title": "Gan To Kagaku Ryoho"}, {"key": "ref21", "DOI": "10.1002/jbm.a.30490", "doi-asserted-by": "publisher"}, {"key": "ref22", "DOI": "10.1021/mp300213g", "doi-asserted-by": "publisher"}, {"key": "ref23", "DOI": "10.1016/j.polymer.2012.05.056", "doi-asserted-by": "publisher"}, {"key": "ref24", "DOI": "10.1111/j.1349-7006.2009.01103.x", "doi-asserted-by": "publisher"}, {"key": "ref25", "DOI": "10.1038/sj.bjc.6603855", "doi-asserted-by": "publisher"}, {"key": "ref26", "DOI": "10.1038/sj.bjc.6602204", "doi-asserted-by": "publisher"}, {"key": "ref27", "author": "Chabner", "year": "2011", "series-title": "Cancer Chemotherapy and Biotherapy: Principles and Practice"}, {"key": "ref28", "first-page": "423", "article-title": "Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following iv infusion of [14C] CPT-11 in cancer patients", "volume": "28", "author": "latter", "year": "2000", "journal-title": "Drug Metab. Dispos."}, {"key": "ref29", "DOI": "10.1200/JCO.1993.11.11.2194", "doi-asserted-by": "publisher"}, {"key": "ref30", "DOI": "10.1016/j.actbio.2008.11.010", "doi-asserted-by": "publisher"}, {"key": "ref31", "DOI": "10.1021/bm034247a", "doi-asserted-by": "publisher"}, {"key": "ref32", "DOI": "10.1002/marc.1993.030140901", "doi-asserted-by": "publisher"}, {"key": "ref33", "DOI": "10.1007/s11671-010-9583-4", "doi-asserted-by": "publisher"}, {"key": "ref34", "DOI": "10.1166/jbn.2012.1358", "doi-asserted-by": "publisher"}, {"key": "ref35", "DOI": "10.1016/j.addr.2004.02.014", "doi-asserted-by": "publisher"}, {"key": "ref36", "DOI": "10.1021/ma00005a010", "doi-asserted-by": "publisher"}, {"key": "ref37", "DOI": "10.3390/pharmaceutics10020057", "doi-asserted-by": "publisher"}, {"key": "ref38", "DOI": "10.1021/ja00449a004", "doi-asserted-by": "publisher"}, {"key": "ref39", "DOI": "10.1074/jbc.270.32.19073", "doi-asserted-by": "publisher"}, {"key": "ref40", "DOI": "10.1016/j.bbrc.2013.11.064", "doi-asserted-by": "publisher"}, {"key": "ref41", "first-page": "1472", "article-title": "Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase", "volume": "54", "author": "Schwartz", "year": "1994", "journal-title": "Cancer Res."}, {"key": "ref42", "DOI": "10.3892/or.2011.1310", "doi-asserted-by": "publisher"}, {"key": "ref43", "DOI": "10.1007/s00259-014-2712-z", "doi-asserted-by": "publisher"}, {"key": "ref44", "DOI": "10.1093/jnci/88.16.1110", "doi-asserted-by": "publisher"}, {"key": "ref45", "DOI": "10.1038/bjc.2011.74", "doi-asserted-by": "publisher"}, {"key": "ref46", "DOI": "10.1002/cyto.990110305", "doi-asserted-by": "publisher"}, {"key": "ref47", "DOI": "10.1093/oxfordjournals.jbchem.a121896", "doi-asserted-by": "publisher"}, {"key": "ref48", "DOI": "10.1038/sj.bjc.6690364", "doi-asserted-by": "publisher"}, {"key": "ref49", "DOI": "10.1016/j.colsurfb.2014.08.011", "doi-asserted-by": "publisher"}, {"key": "ref50", "DOI": "10.1016/j.ijpharm.2008.09.004", "doi-asserted-by": "publisher"}, {"key": "ref51", "DOI": "10.3390/molecules20022857", "doi-asserted-by": "publisher"}, {"key": "ref52", "DOI": "10.3109/10717544.2013.875603", "doi-asserted-by": "publisher"}, {"key": "ref53", "DOI": "10.2147/IJN.S76104", "doi-asserted-by": "publisher"}], "container-title": ["Nanomaterials"], "language": "en", "link": [{"URL": "http://www.mdpi.com/2079-4991/8/12/1041/pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 12, 14]], "date-time": "2018-12-14T10:17:36Z", "timestamp": 1544782656000}, "score": 18.658968, "issued": {"date-parts": [[2018, 12, 13]]}, "references-count": 53, "journal-issue": {"published-online": {"date-parts": [[2018, 12]]}, "issue": "12"}, "alternative-id": ["nano8121041"], "URL": "http://dx.doi.org/10.3390/nano8121041", "relation": {"cites": []}, "ISSN": ["2079-4991"], "issn-type": [{"value": "2079-4991", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T16:58:41Z", "timestamp": 1574441921836}, "reference-count": 13, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1945, 6, 1]], "date-time": "1945-06-01T00:00:00Z", "timestamp": -775872000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of the American Pharmaceutical Association (Scientific ed.)"], "published-print": {"date-parts": [[1945, 6]]}, "DOI": "10.1002/jps.3030340605", "type": "journal-article", "created": {"date-parts": [[2010, 7, 2]], "date-time": "2010-07-02T17:39:47Z", "timestamp": 1278092387000}, "page": "170-172", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Notes on Mexican Drugs, Plants, and Foods. III. Ahuauhtli, the Mexican Caviar"], "prefix": "10.1016", "volume": "34", "author": [{"given": "Marcel", "family": "Bachstez", "sequence": "first", "affiliation": []}, {"given": "Altagracia", "family": "Aragon", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of the American Pharmaceutical Association (Scientific ed.)"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0095955315308805?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0095955315308805?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 10]], "date-time": "2018-12-10T01:50:07Z", "timestamp": 1544406607000}, "score": 18.53524, "issued": {"date-parts": [[1945, 6]]}, "references-count": 13, "journal-issue": {"published-print": {"date-parts": [[1945, 6]]}, "issue": "6"}, "alternative-id": ["S0095955315308805"], "URL": "http://dx.doi.org/10.1002/jps.3030340605", "ISSN": ["0095-9553"], "issn-type": [{"value": "0095-9553", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T17:07:22Z", "timestamp": 1574442442374}, "reference-count": 14, "publisher": "Elsevier BV", "issue": "8", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1941, 8, 1]], "date-time": "1941-08-01T00:00:00Z", "timestamp": -896832000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of the American Pharmaceutical Association (Scientific ed.)"], "published-print": {"date-parts": [[1941, 8]]}, "DOI": "10.1002/jps.3030300806", "type": "journal-article", "created": {"date-parts": [[2010, 7, 4]], "date-time": "2010-07-04T09:09:20Z", "timestamp": 1278234560000}, "page": "218-219", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Notes on Mexican Drugs\u2014I. Zapote borracho (Lucuma salicifolia kunth, sapotac)"], "prefix": "10.1016", "volume": "30", "author": [{"given": "Marcel", "family": "Bachstez", "sequence": "first", "affiliation": []}, {"given": "Altagracia", "family": "Aragon", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of the American Pharmaceutical Association (Scientific ed.)"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S009595531530370X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S009595531530370X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 9]], "date-time": "2018-12-09T22:54:16Z", "timestamp": 1544396056000}, "score": 18.53524, "issued": {"date-parts": [[1941, 8]]}, "references-count": 14, "journal-issue": {"published-print": {"date-parts": [[1941, 8]]}, "issue": "8"}, "alternative-id": ["S009595531530370X"], "URL": "http://dx.doi.org/10.1002/jps.3030300806", "ISSN": ["0095-9553"], "issn-type": [{"value": "0095-9553", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T23:59:22Z", "timestamp": 1574207962981}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "Supplement 2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drugs"], "published-print": {"date-parts": [[1999]]}, "DOI": "10.2165/00003495-199958002-00080", "type": "journal-article", "created": {"date-parts": [[2006, 5, 22]], "date-time": "2006-05-22T09:46:08Z", "timestamp": 1148291168000}, "page": "252-253", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Pharmacokinetics of Oral and Intravenous Clinafloxacin"], "prefix": "10.1007", "volume": "58", "author": [{"given": "EJ", "family": "Randinitis", "sequence": "first", "affiliation": []}, {"given": "J", "family": "Brodfuehrer", "sequence": "additional", "affiliation": []}, {"given": "AB", "family": "Vassos", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Drugs"], "language": "en", "deposited": {"date-parts": [[2013, 1, 20]], "date-time": "2013-01-20T14:36:07Z", "timestamp": 1358692567000}, "score": 18.086124, "subtitle": [""], "issued": {"date-parts": [[1999]]}, "references-count": 0, "journal-issue": {"issue": "Supplement 2"}, "URL": "http://dx.doi.org/10.2165/00003495-199958002-00080", "ISSN": ["0012-6667"], "issn-type": [{"value": "0012-6667", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:51:31Z", "timestamp": 1574491891074}, "reference-count": 16, "publisher": "Wiley", "issue": "S1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 11535, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["British Journal of Clinical Pharmacology"], "published-print": {"date-parts": [[1984, 2]]}, "DOI": "10.1111/j.1365-2125.1984.tb02587.x", "type": "journal-article", "created": {"date-parts": [[2012, 7, 26]], "date-time": "2012-07-26T20:38:20Z", "timestamp": 1343335100000}, "page": "91S-93S", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Effects of centrally depressant drugs on pupillary function: significance for normal and diseased subjects."], "prefix": "10.1111", "volume": "18", "author": [{"given": "AB", "family": "Safran", "sequence": "first", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2012, 7, 26]]}, "reference": [{"key": "10.1111/j.1365-2125.1984.tb02587.x-BIB1|cit2", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1111/j.1755-3768.1979.tb06668.x", "article-title": "The effect of oxazepam on ocular readaptation time", "volume": "57", "author": "Bergman", "year": "1979", "journal-title": "Acta Ophthalmologica"}, {"key": "10.1111/j.1365-2125.1984.tb02587.x-BIB2|cit3", "doi-asserted-by": "crossref", "first-page": "210", "DOI": "10.1016/0006-8993(81)91291-9", "article-title": "Benzodiazepine and GABA receptors in the rat retina: effect of light and dark adaptation", "volume": "216", "author": "Biaggio", "year": "1981", "journal-title": "Brain Res."}, {"key": "10.1111/j.1365-2125.1984.tb02587.x-BIB3|cit4", "doi-asserted-by": "crossref", "first-page": "303", "DOI": "10.1016/0006-8993(83)90633-9", "article-title": "Brainstem connections to Edinger-Westphal nucleus of the cat: a retrograde tracer study", "volume": "261", "author": "Breen", "year": "1983", "journal-title": "Brain Res."}, {"key": "10.1111/j.1365-2125.1984.tb02587.x-BIB4|cit5", "author": "Haefely", "first-page": "21", "year": "1983", "volume-title": "The benzodiazepines: from molecular biology to clinical practice"}, {"key": "10.1111/j.1365-2125.1984.tb02587.x-BIB5|cit6", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1016/0006-8993(78)90534-6", "article-title": "Cerebellar influence on parasympathetic neurones innervating intra-occular muscles", "volume": "159", "author": "Hulthorn", "year": "1978", "journal-title": "Brain Res."}, {"key": "10.1111/j.1365-2125.1984.tb02587.x-BIB6|cit7", "author": "Ishikawa", "first-page": "288", "year": "1977", "volume-title": "Drugs and occular tissues", "DOI": "10.1159/000400379", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1365-2125.1984.tb02587.x-BIB7|cit8", "doi-asserted-by": "crossref", "first-page": "956", "DOI": "10.1002/jps.2600670722", "article-title": "Effect of diazepam on cognition via pupillometry", "volume": "67", "author": "Kotzan", "year": "1978", "journal-title": "J. pharm. Sci."}, {"key": "10.1111/j.1365-2125.1984.tb02587.x-BIB8|cit9", "first-page": "259", "article-title": "Pupillenreflexst\u00f6rungen bei Infarkten der arteria cerebri posterior. II. Pupilloperimetrischer Nach-weis von Parazentralskotomen", "volume": "229", "author": "Reuther", "year": "1981", "journal-title": "Arch. Psychiatr. Nervenkr."}, {"key": "10.1111/j.1365-2125.1984.tb02587.x-BIB9|cit10", "first-page": "308", "article-title": "Drugs and PGO waves in the lateral geniculate body of the curarized cat. IV. The effects of acetylcholine, GABA and benzodiazepines on PGO wave activity", "volume": "219", "author": "Ruch-Monachon", "year": "1976", "journal-title": "Arch. int. Pharmacodyn. Ther."}, {"key": "10.1111/j.1365-2125.1984.tb02587.x-BIB10|cit11", "unstructured": "Safran , A. B. Roth , A. 1982 Le r\u00e9flex pupillaire photomoteur dans l'examen fonctionnel du nerf optique Bull. Soc. belge Ophtal. 199 200 233"}, {"key": "10.1111/j.1365-2125.1984.tb02587.x-BIB11|cit12", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1159/000309167", "article-title": "Pupil cycle induction test: a way of evaluating the pupillary light reflex", "volume": "183", "author": "Safran", "year": "1981a", "journal-title": "Ophthalmologica"}, {"key": "10.1111/j.1365-2125.1984.tb02587.x-BIB12|cit13", "doi-asserted-by": "crossref", "first-page": "214", "DOI": "10.1159/000309168", "article-title": "Influence of central depressant drugs on pupil function: an evaluation with the pupil cycle induction test", "volume": "183", "author": "Safran", "year": "1981b", "journal-title": "Ophthalmologica"}, {"key": "10.1111/j.1365-2125.1984.tb02587.x-BIB13|cit14", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1016/0014-2999(80)90306-4", "article-title": "\u2018Brain-specific\u2019 benzodiazepine receptors are localized in the inner plexiform layer of rat retina", "volume": "66", "author": "Skolnik", "year": "1980", "journal-title": "Eur. J. Pharmac."}, {"key": "10.1111/j.1365-2125.1984.tb02587.x-BIB14|cit15", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1016/0006-8993(73)90595-7", "article-title": "The modification of the pupillary light reflex by chlorpromazine, diazepam, and pentobarbital", "volume": "50", "author": "Sigg", "year": "1973", "journal-title": "Brain Res."}, {"key": "10.1111/j.1365-2125.1984.tb02587.x-BIB15|cit16", "first-page": "377", "article-title": "Pupillary signs in the diagnosis of optic nerve disease", "volume": "96", "author": "Thompson", "year": "1976", "journal-title": "Trans. Ophthalmol. Soc. U.K."}, {"key": "10.1111/j.1365-2125.1984.tb02587.x-BIB16|cit17", "doi-asserted-by": "crossref", "first-page": "513", "DOI": "10.1016/0042-6989(81)90097-3", "article-title": "Pupillary light reflex in humans: evidence for an unbalanced pathway from nasal retina and for signal cancellation in brainstem", "volume": "21", "author": "Wyatt", "year": "1981", "journal-title": "Vision Res."}], "container-title": ["British Journal of Clinical Pharmacology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1984.tb02587.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 20]], "date-time": "2017-06-20T22:01:46Z", "timestamp": 1497996106000}, "score": 17.943092, "issued": {"date-parts": [[1984, 2]]}, "references-count": 16, "journal-issue": {"published-print": {"date-parts": [[1984, 2]]}, "issue": "S1"}, "URL": "http://dx.doi.org/10.1111/j.1365-2125.1984.tb02587.x", "relation": {"cites": []}, "ISSN": ["0306-5251"], "issn-type": [{"value": "0306-5251", "type": "print"}]}, {"institution": {"name": "The University of Hong Kong", "place": ["Pokfulam Road, Hong Kong SAR"], "department": ["Medicine"], "acronym": ["HKU"]}, "indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T01:22:04Z", "timestamp": 1574472124576}, "reference-count": 0, "publisher": "The University of Hong Kong Libraries", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.5353/th_b4663202", "type": "dissertation", "created": {"date-parts": [[2012, 4, 25]], "date-time": "2012-04-25T05:58:35Z", "timestamp": 1335333515000}, "approved": {"date-parts": [[2011]]}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Heat shock protein 90 inhibitor 17-AAG potentiates anticancer activity of bortezomib in NK cell malignancies"], "prefix": "10.5353", "author": [{"given": "Hoi-ching", "family": "Chan", "sequence": "first", "affiliation": []}], "member": "3298", "deposited": {"date-parts": [[2015, 5, 11]], "date-time": "2015-05-11T13:47:15Z", "timestamp": 1431352035000}, "score": 17.729288, "degree": ["Master of Medical Sciences"], "issued": {"date-parts": [[null]]}, "references-count": 0, "URL": "http://dx.doi.org/10.5353/th_b4663202"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T13:35:00Z", "timestamp": 1574516100776}, "reference-count": 37, "publisher": "Springer Science and Business Media LLC", "issue": "4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2011, 6, 8]], "date-time": "2011-06-08T00:00:00Z", "timestamp": 1307491200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Invest New Drugs"], "published-print": {"date-parts": [[2012, 8]]}, "DOI": "10.1007/s10637-011-9702-9", "type": "journal-article", "created": {"date-parts": [[2011, 6, 7]], "date-time": "2011-06-07T03:56:46Z", "timestamp": 1307419006000}, "page": "1379-1388", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitor"], "prefix": "10.1007", "volume": "30", "author": [{"given": "Lih-Ching", "family": "Hsu", "sequence": "first", "affiliation": []}, {"given": "David E.", "family": "Durrant", "sequence": "additional", "affiliation": []}, {"given": "Ching-Chun", "family": "Huang", "sequence": "additional", "affiliation": []}, {"given": "Nai-Wen", "family": "Chi", "sequence": "additional", "affiliation": []}, {"given": "Riccardo", "family": "Baruchello", "sequence": "additional", "affiliation": []}, {"given": "Riccardo", "family": "Rondanin", "sequence": "additional", "affiliation": []}, {"given": "Cinzia", "family": "Rullo", "sequence": "additional", "affiliation": []}, {"given": "Paolo", "family": "Marchetti", "sequence": "additional", "affiliation": []}, {"given": "Giuseppina", "family": "Grisolia", "sequence": "additional", "affiliation": []}, {"given": "Daniele", "family": "Simoni", "sequence": "additional", "affiliation": []}, {"given": "Ray M.", "family": "Lee", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 6, 8]]}, "reference": [{"key": "9702_CR1", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1038/nrc1317", "volume": "4", "author": "MA Jordan", "year": "2004", "unstructured": "Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4:253\u2013265. doi: 10.1038/nrc1317", "journal-title": "Nat Rev Cancer"}, {"key": "9702_CR2", "doi-asserted-by": "crossref", "first-page": "421", "DOI": "10.1053/j.seminoncol.2006.04.006", "volume": "33", "author": "EK Rowinsky", "year": "2006", "unstructured": "Rowinsky EK, Calvo E (2006) Novel agents that target tublin and related elements. Semin Oncol 33:421\u2013435. doi: 10.1053/j.seminoncol.2006.04.006", "journal-title": "Semin Oncol"}, {"key": "9702_CR3", "doi-asserted-by": "crossref", "first-page": "4428", "DOI": "10.1200/JCO.2003.12.986", "volume": "21", "author": "JP Stevenson", "year": "2003", "unstructured": "Stevenson JP, Rosen M, Sun W et al (2003) Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow. J Clin Oncol 21:4428\u20134438. doi: 10.1200/JCO.2003.12.986", "journal-title": "J Clin Oncol"}, {"key": "9702_CR4", "doi-asserted-by": "crossref", "first-page": "96", "DOI": "10.1158/1078-0432.CCR-0364-3", "volume": "10", "author": "MM Cooney", "year": "2004", "unstructured": "Cooney MM, Radivoyevitch T, Dowlati A et al (2004) Cardiovascular safety profile of combretastatin a4 phosphate in a single-dose phase I study in patients with advanced cancer. Clin Cancer Res 10:96\u2013100. doi: 10.1158/1078-0432.CCR-0364-3", "journal-title": "Clin Cancer Res"}, {"key": "9702_CR5", "doi-asserted-by": "crossref", "first-page": "2815", "DOI": "10.1200/JCO.2003.05.185", "volume": "21", "author": "GJ Rustin", "year": "2003", "unstructured": "Rustin GJ, Galbraith SM, Anderson H et al (2003) Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic results. J Clin Oncol 21:2815\u20132822. doi: 10.1200/JCO.2003.05.185", "journal-title": "J Clin Oncol"}, {"key": "9702_CR6", "doi-asserted-by": "crossref", "first-page": "2823", "DOI": "10.1200/JCO.2003.05.186", "volume": "21", "author": "HL Anderson", "year": "2003", "unstructured": "Anderson HL, Yap JT, Miller MP, Robbins A, Jones T, Price PM (2003) Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate. J Clin Oncol 21:2823\u20132830. doi: 10.1200/JCO.2003.05.186", "journal-title": "J Clin Oncol"}, {"key": "9702_CR7", "first-page": "1974", "volume": "8", "author": "DC Blakey", "year": "2002", "unstructured": "Blakey DC, Westwood FR, Walker M et al (2002) Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models. Clin Cancer Res 8:1974\u20131983", "journal-title": "Clin Cancer Res"}, {"key": "9702_CR8", "doi-asserted-by": "crossref", "first-page": "1491", "DOI": "10.1200/JCO.2005.02.7458", "volume": "24", "author": "LV Beerepoot", "year": "2006", "unstructured": "Beerepoot LV, Radema SA, Witteveen EO et al (2006) Phase I clinical evaluation of weekly administration of the novel vascular-targeting agent, ZD6126, in patients with solid tumors. J Clin Oncol 24:1491\u20131498. doi: 10.1200/JCO.2005.02.7458", "journal-title": "J Clin Oncol"}, {"key": "9702_CR9", "first-page": "2735", "volume": "8", "author": "SM Nabha", "year": "2002", "unstructured": "Nabha SM, Mohammad RM, Dandashi MH et al (2002) Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly (ADP-ribose) polymerase cleavage. Clin Cancer Res 8:2735\u20132741", "journal-title": "Clin Cancer Res"}, {"key": "9702_CR10", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1038/nrc2049", "volume": "7", "author": "JR Jackson", "year": "2007", "unstructured": "Jackson JR, Patrick DR, Dar MM, Huang PS (2007) Targeted anti-mitotic therapies: can we improve on tubulin agents? Nat Rev Cancer 7:107\u2013117. doi: 10.1038/nrc2049", "journal-title": "Nat Rev Cancer"}, {"key": "9702_CR11", "doi-asserted-by": "crossref", "first-page": "399", "DOI": "10.1007/s12094-006-0193-7", "volume": "8", "author": "M Malumbres", "year": "2006", "unstructured": "Malumbres M (2006) Therapeutic opportunities to control tumor cell cycles. Clin Transl Oncol 8:399\u2013408. doi: 10.1007/s12094-006-0193-7", "journal-title": "Clin Transl Oncol"}, {"key": "9702_CR12", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1016/S1470-2045(03)01321-4", "volume": "5", "author": "C Swanton", "year": "2004", "unstructured": "Swanton C (2004) Cell-cycle targeted therapies. Lancet Oncol 5:27\u201336. doi: 10.1016/S1470-2045(03)01321-4", "journal-title": "Lancet Oncol"}, {"key": "9702_CR13", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1007/s11912-004-0024-3", "volume": "6", "author": "Y Dai", "year": "2004", "unstructured": "Dai Y, Grant S (2004) Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents. Curr Oncol Rep 6:123\u2013130. doi: 10.1007/s11912-004-0024-3", "journal-title": "Curr Oncol Rep"}, {"key": "9702_CR14", "doi-asserted-by": "crossref", "first-page": "4106", "DOI": "10.1073/pnas.0608798104", "volume": "104", "author": "MG Manfredi", "year": "2007", "unstructured": "Manfredi MG, Ecsedy JA, Meetze KA et al (2007) Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase. Proc Natl Acad Sci U S A 104:4106\u20134111. doi: 10.1073/pnas.0608798104", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9702_CR15", "doi-asserted-by": "crossref", "first-page": "2846", "DOI": "10.4161/cc.6.22.4940", "volume": "6", "author": "RK Tyler", "year": "2007", "unstructured": "Tyler RK, Shpiro N, Marquez R, Eyers PA (2007) VX-680 inhibits Aurora A and Aurora B kinase activity in human cells. Cell Cycle 6:2846\u20132854. doi: 10.4161/cc.6.22.4940", "journal-title": "Cell Cycle"}, {"key": "9702_CR16", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.2174/1568026053507660", "volume": "5", "author": "C McInnes", "year": "2005", "unstructured": "McInnes C, Mezna M, Fischer PM (2005) Progress in the discovery of polo-like kinase inhibitors. Curr Top Med Chem 5:181\u2013197", "journal-title": "Curr Top Med Chem"}, {"key": "9702_CR17", "doi-asserted-by": "crossref", "first-page": "971", "DOI": "10.1126/science.286.5441.971", "volume": "286", "author": "TU Mayer", "year": "1999", "unstructured": "Mayer TU, Kapoor TM, Haggarty SJ, King RW, Schreiber SL, Mitchison TJ (1999) Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 286:971\u2013974. doi: 10.1126/science.286.5441.971", "journal-title": "Science"}, {"key": "9702_CR18", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1007/s10637-007-9098-8", "volume": "26", "author": "PA Tang", "year": "2008", "unstructured": "Tang PA, Siu LL, Chen EX et al (2008) Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck. Invest New Drugs 26:257\u2013264. doi: 10.1007/s10637-007-9098-8", "journal-title": "Invest New Drugs"}, {"key": "9702_CR19", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1007/s10637-007-9097-9", "volume": "26", "author": "CW Lee", "year": "2008", "unstructured": "Lee CW, B\u00e9langer K, Rao SC et al (2008) A phase II study of ispinesib (SB-715992) in patients with metastatic or recurrent malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group trial. Invest New Drugs 26:249\u2013255. doi: 10.1007/s10637-007-9097-9", "journal-title": "Invest New Drugs"}, {"key": "9702_CR20", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1186/1747-1028-1-31", "volume": "1", "author": "MT Valentine", "year": "2006", "unstructured": "Valentine MT, Fordyce PM, Block SM (2006) Eg5 steps it up! Cell Div 1:31. doi: 10.1186/1747-1028-1-31", "journal-title": "Cell Div"}, {"key": "9702_CR21", "doi-asserted-by": "crossref", "first-page": "127", "DOI": "10.2174/1568026053507697", "volume": "5", "author": "G Bergnes", "year": "2005", "unstructured": "Bergnes G, Brejc K, Belmont L (2005) Mitotic kinesins: prospects for antimitotic drug discovery. Curr Top Med Chem 5:127\u2013145. doi: 10.2174/1568026053507697", "journal-title": "Curr Top Med Chem"}, {"key": "9702_CR22", "doi-asserted-by": "crossref", "first-page": "390", "DOI": "10.1002/ajh.21104", "volume": "83", "author": "TM Cao", "year": "2008", "unstructured": "Cao TM, Durrant D, Tripathi A et al (2008) Stilbene derivatives that are colchicine site microtubule inhibitors have anti-leukemic activity and minimal systemic toxicity. Am J Hematol 83:390\u2013397. doi: 10.1002/ajh.21104", "journal-title": "Am J Hematol"}, {"key": "9702_CR23", "doi-asserted-by": "crossref", "first-page": "14302", "DOI": "10.1021/bi991323e", "volume": "38", "author": "R Bai", "year": "1999", "unstructured": "Bai R, Durso NA, Sackett DL, Hamel E (1999) Interactions of the sponge-derived antimitotic tripeptide hemiasterlin with tubulin: comparison with dolastatin 10 and cryptophycin 1. Biochemistry 38:14302\u201314310. doi: 10.1021/bi991323e", "journal-title": "Biochemistry"}, {"key": "9702_CR24", "first-page": "1838", "volume": "63", "author": "F Loganzo", "year": "2003", "unstructured": "Loganzo F, Discafani CM, Annable T et al (2003) HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo. Cancer Res 63:1838\u20131845", "journal-title": "Cancer Res"}, {"key": "9702_CR25", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1021/np020375t", "volume": "66", "author": "JA Nieman", "year": "2003", "unstructured": "Nieman JA, Coleman JE, Wallace DJ et al (2003) Synthesis and antimitotic/cytotoxic activity of hemiasterlin analogues. J Nat Prod 66:183\u2013199. doi: 10.1021/np020375t", "journal-title": "J Nat Prod"}, {"key": "9702_CR26", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1007/s10637-005-6735-y", "volume": "23", "author": "EA Perez", "year": "2005", "unstructured": "Perez EA, Hillman DW, Fishkin PA et al (2005) Phase II trial of dolastatin-10 in patients with advanced breast cancer. Invest New Drugs 23:257\u2013261. doi: 10.1007/s10637-005-6735-y", "journal-title": "Invest New Drugs"}, {"key": "9702_CR27", "doi-asserted-by": "crossref", "first-page": "489", "DOI": "10.1007/s10637-005-2909-x", "volume": "23", "author": "HL Kindler", "year": "2005", "unstructured": "Kindler HL, Tothy PK, Wolff R et al (2005) Phase II trials of dolastatin-10 in advanced pancreaticobiliary cancers. Invest New Drugs 23:489\u2013493. doi: 10.1007/s10637-005-2909-x", "journal-title": "Invest New Drugs"}, {"key": "9702_CR28", "doi-asserted-by": "crossref", "first-page": "2852", "DOI": "10.1158/1535-7163.MCT-09-0301", "volume": "8", "author": "G Kuznetsov", "year": "2009", "unstructured": "Kuznetsov G, TenDyke K, Towle MJ et al (2009) Tubulin-based antimitotic mechanism of E7974, a novel analogue of the marine sponge natural product hemiasterlin. Mol Cancer Ther 8:2852\u20132860. doi: 10.1158/1535-7163.MCT-09-0301", "journal-title": "Mol Cancer Ther"}, {"key": "9702_CR29", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1007/s10637-008-9139-y", "volume": "27", "author": "D Durrant", "year": "2009", "unstructured": "Durrant D, Richard J, Tripathi A et al (2009) Development of water soluble derivatives of cis-3, 4\u2032, 5-trimethoxy-3\u2032-aminostilbene for optimization and use in cancer therapy. Invest New Drugs 27:41\u201352. doi: 10.1007/s10637-008-9139-y", "journal-title": "Invest New Drugs"}, {"key": "9702_CR30", "doi-asserted-by": "crossref", "first-page": "4884", "DOI": "10.1073/pnas.89.11.4884", "volume": "89", "author": "MR Webb", "year": "1992", "unstructured": "Webb MR (1992) A continuous spectrophotometric assay for inorganic phosphate and for measuring phosphate release kinetics in biological systems. Proc Natl Acad Sci U S A 89:4884\u20134887", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9702_CR31", "doi-asserted-by": "crossref", "first-page": "355", "DOI": "10.1007/s002800050989", "volume": "44", "author": "LG Wang", "year": "1999", "unstructured": "Wang LG, Liu XM, Kreis W, Budman DR (1999) The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Cancer Chemother Pharmacol 44:355\u2013361", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "9702_CR32", "doi-asserted-by": "crossref", "first-page": "4301", "DOI": "10.1002/j.1460-2075.1991.tb05008.x", "volume": "10", "author": "JB Millar", "year": "1991", "unstructured": "Millar JB, McGowan CH, Lenaers G, Jones R, Russell P (1991) p80cdc25 mitotic inducer is the tyrosine phosphatase that activates p34cdc2 kinase in fission yeast. EMBO J 10:4301\u20134309", "journal-title": "EMBO J"}, {"key": "9702_CR33", "doi-asserted-by": "crossref", "first-page": "172", "DOI": "10.1038/16488", "volume": "397", "author": "A Lopez-Girona", "year": "1999", "unstructured": "Lopez-Girona A, Furnari B, Mondesert O, Russell P (1999) Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature 397:172\u2013175. doi: 10.1038/16488", "journal-title": "Nature"}, {"key": "9702_CR34", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1038/nature03566", "volume": "435", "author": "B Gigant", "year": "2005", "unstructured": "Gigant B, Wang C, Ravelli RB et al (2005) Structural basis for the regulation of tubulin by vinblastine. Nature 435:519\u2013522. doi: 10.1038/nature03566", "journal-title": "Nature"}, {"key": "9702_CR35", "doi-asserted-by": "crossref", "first-page": "198", "DOI": "10.1038/nature02393", "volume": "428", "author": "RB Ravelli", "year": "2004", "unstructured": "Ravelli RB, Gigant B, Curmi PA et al (2004) Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature 428:198\u2013202. doi: 10.1038/nature02393", "journal-title": "Nature"}, {"key": "9702_CR36", "doi-asserted-by": "crossref", "first-page": "6844", "DOI": "10.1021/bi0474766", "volume": "44", "author": "M Nunes", "year": "2005", "unstructured": "Nunes M, Kaplan J, Wooters J et al (2005) Two photo affinity analogues of tripeptide, hemiasterlin, exclusively label alpha-tubulin. Biochemistry 44:6844\u20136857. doi: 10.1021/bi0474766", "journal-title": "Biochemistry"}, {"key": "9702_CR37", "doi-asserted-by": "crossref", "first-page": "15871", "DOI": "10.1021/bi051268b", "volume": "44", "author": "M Ravi", "year": "2005", "unstructured": "Ravi M, Zask A, Rush TS 3rd (2005) Structure-based identification of the binding site for the hemiasterlin analogue HTI-286 on tubulin. Biochemistry 44:15871\u201315879. doi: 10.1021/bi051268b", "journal-title": "Biochemistry"}], "container-title": ["Investigational New Drugs"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s10637-011-9702-9.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s10637-011-9702-9/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s10637-011-9702-9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 11]], "date-time": "2019-06-11T13:07:18Z", "timestamp": 1560258438000}, "score": 17.587618, "issued": {"date-parts": [[2011, 6, 8]]}, "references-count": 37, "journal-issue": {"published-print": {"date-parts": [[2012, 8]]}, "issue": "4"}, "alternative-id": ["9702"], "URL": "http://dx.doi.org/10.1007/s10637-011-9702-9", "relation": {"cites": []}, "ISSN": ["0167-6997", "1573-0646"], "issn-type": [{"value": "0167-6997", "type": "print"}, {"value": "1573-0646", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T17:06:28Z", "timestamp": 1574442388386}, "reference-count": 5, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1942, 5, 1]], "date-time": "1942-05-01T00:00:00Z", "timestamp": -873244800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of the American Pharmaceutical Association (Scientific ed.)"], "published-print": {"date-parts": [[1942, 5]]}, "DOI": "10.1002/jps.3030310505", "type": "journal-article", "created": {"date-parts": [[2010, 7, 4]], "date-time": "2010-07-04T03:26:05Z", "timestamp": 1278213965000}, "page": "145-146", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Notes on Mexican drugs. II. Characteristics and composition of the fatty oil from \u201cGusanos de Maguey\u201d (caterpillars of Acentrocneme hesperiaris)"], "prefix": "10.1016", "volume": "31", "author": [{"given": "Marcel", "family": "Bachstez", "sequence": "first", "affiliation": []}, {"given": "Altagracia", "family": "Aragon", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of the American Pharmaceutical Association (Scientific ed.)"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0095955315304753?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0095955315304753?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 9]], "date-time": "2018-12-09T23:26:31Z", "timestamp": 1544397991000}, "score": 17.385029, "issued": {"date-parts": [[1942, 5]]}, "references-count": 5, "journal-issue": {"published-print": {"date-parts": [[1942, 5]]}, "issue": "5"}, "alternative-id": ["S0095955315304753"], "URL": "http://dx.doi.org/10.1002/jps.3030310505", "ISSN": ["0095-9553"], "issn-type": [{"value": "0095-9553", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T11:35:08Z", "timestamp": 1575545708175}, "reference-count": 0, "publisher": "International Institute of Anticancer Research", "issue": "11", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Anticancer Res"], "published-print": {"date-parts": [[2019, 11]]}, "DOI": "10.21873/anticanres.13821", "type": "journal-article", "created": {"date-parts": [[2019, 11, 8]], "date-time": "2019-11-08T22:49:23Z", "timestamp": 1573253363000}, "page": "6135-6144", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Suppression of Carnosine on Adhesion and Extravasation of Human Colorectal Cancer Cells"], "prefix": "10.21873", "volume": "39", "author": [{"given": "CHIH-CHUNG", "family": "WU", "sequence": "first", "affiliation": []}, {"given": "PO-YU", "family": "LAI", "sequence": "additional", "affiliation": []}, {"given": "SHUCHEN", "family": "HSIEH", "sequence": "additional", "affiliation": []}, {"given": "CHING-CHING", "family": "CHENG", "sequence": "additional", "affiliation": []}, {"given": "SHU-LING", "family": "HSIEH", "sequence": "additional", "affiliation": []}], "member": "9336", "published-online": {"date-parts": [[2019, 11, 8]]}, "container-title": ["Anticancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.21873/anticanres.13821", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 8]], "date-time": "2019-11-08T22:49:37Z", "timestamp": 1573253377000}, "score": 17.33666, "issued": {"date-parts": [[2019, 11]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2019, 11, 8]]}, "published-print": {"date-parts": [[2019, 11]]}, "issue": "11"}, "alternative-id": ["10.21873/anticanres.13821"], "URL": "http://dx.doi.org/10.21873/anticanres.13821", "ISSN": ["0250-7005", "1791-7530"], "issn-type": [{"value": "0250-7005", "type": "print"}, {"value": "1791-7530", "type": "electronic"}], "subject": ["Cancer Research", "Oncology", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T15:53:24Z", "timestamp": 1574178804503}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Paediatric Drugs"], "published-print": {"date-parts": [[2001]]}, "DOI": "10.2165/00128072-200103060-00005", "type": "journal-article", "created": {"date-parts": [[2006, 1, 23]], "date-time": "2006-01-23T05:28:48Z", "timestamp": 1137994128000}, "page": "438-439", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Rasburicase"], "prefix": "10.1007", "volume": "3", "author": [{"given": "Ching-Hon", "family": "Pui", "sequence": "first", "affiliation": []}], "member": "297", "container-title": ["Paediatric Drugs"], "language": "en", "deposited": {"date-parts": [[2013, 2, 26]], "date-time": "2013-02-26T21:17:47Z", "timestamp": 1361913467000}, "score": 17.18667, "subtitle": ["A Viewpoint by Ching-Hon Pui"], "issued": {"date-parts": [[2001]]}, "references-count": 0, "journal-issue": {"issue": "6"}, "URL": "http://dx.doi.org/10.2165/00128072-200103060-00005", "ISSN": ["1174-5878"], "issn-type": [{"value": "1174-5878", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T05:39:03Z", "timestamp": 1574401143761}, "reference-count": 0, "publisher": "Informa UK Limited", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Psychoactive Drugs"], "published-print": {"date-parts": [[2010, 12]]}, "DOI": "10.1080/02791072.2010.10400714", "type": "journal-article", "created": {"date-parts": [[2011, 9, 20]], "date-time": "2011-09-20T20:13:25Z", "timestamp": 1316549605000}, "page": "513-514", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The Acid Diaries: A Psychonaut's Guide to the History and Use of LSD"], "prefix": "10.1080", "volume": "42", "author": [{"given": "Gene", "family": "Ching", "sequence": "first", "affiliation": []}], "member": "301", "container-title": ["Journal of Psychoactive Drugs"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1080/02791072.2010.10400714", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 15]], "date-time": "2016-12-15T09:49:50Z", "timestamp": 1481795390000}, "score": 17.174261, "issued": {"date-parts": [[2010, 12]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2010, 12]]}, "issue": "4"}, "alternative-id": ["10.1080/02791072.2010.10400714"], "URL": "http://dx.doi.org/10.1080/02791072.2010.10400714", "ISSN": ["0279-1072", "2159-9777"], "issn-type": [{"value": "0279-1072", "type": "print"}, {"value": "2159-9777", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T12:46:47Z", "timestamp": 1575290807507}, "reference-count": 24, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2008, 9, 1]], "date-time": "2008-09-01T00:00:00Z", "timestamp": 1220227200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["General Hospital Psychiatry"], "published-print": {"date-parts": [[2008, 9]]}, "DOI": "10.1016/j.genhosppsych.2008.04.004", "type": "journal-article", "created": {"date-parts": [[2008, 7, 24]], "date-time": "2008-07-24T08:58:20Z", "timestamp": 1216889900000}, "page": "467-470", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Self-poisoning by drugs and chemicals: variations in demographics, associated factors and final outcomes"], "prefix": "10.1016", "volume": "30", "author": [{"given": "Ahmed Ibrahim", "family": "Fathelrahman", "sequence": "first", "affiliation": []}, {"given": "Ab Fatah", "family": "Ab Rahman", "sequence": "additional", "affiliation": []}, {"given": "Zaininah", "family": "Mohd Zain", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["General Hospital Psychiatry"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0163834308000674?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0163834308000674?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 27]], "date-time": "2018-12-27T02:52:08Z", "timestamp": 1545879128000}, "score": 16.924324, "issued": {"date-parts": [[2008, 9]]}, "references-count": 24, "journal-issue": {"published-print": {"date-parts": [[2008, 9]]}, "issue": "5"}, "alternative-id": ["S0163834308000674"], "URL": "http://dx.doi.org/10.1016/j.genhosppsych.2008.04.004", "ISSN": ["0163-8343"], "issn-type": [{"value": "0163-8343", "type": "print"}], "subject": ["Psychiatry and Mental health"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T10:53:22Z", "timestamp": 1574420002847}, "reference-count": 0, "publisher": "Georg Thieme Verlag KG", "issue": "05", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Planta Med"], "published-print": {"date-parts": [[2010, 3]]}, "DOI": "10.1055/s-0030-1251734", "type": "journal-article", "created": {"date-parts": [[2010, 3, 25]], "date-time": "2010-03-25T02:01:11Z", "timestamp": 1269482471000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Marker Based Detection of Identity and Authenticity of Raw Herbal Drugs and Finished Ayurvedic Products for Quality Control and Standardization"], "prefix": "10.1055", "volume": "76", "author": [{"given": "AB", "family": "Rema Shree", "sequence": "first", "affiliation": []}], "member": "194", "published-online": {"date-parts": [[2010, 3, 24]]}, "container-title": ["Planta Medica"], "language": "en", "link": [{"URL": "http://www.thieme-connect.de/DOI/DOI?10.1055/s-0030-1251734", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 5, 22]], "date-time": "2017-05-22T17:49:00Z", "timestamp": 1495475340000}, "score": 16.779663, "issued": {"date-parts": [[2010, 3]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2010, 3]]}, "issue": "05"}, "URL": "http://dx.doi.org/10.1055/s-0030-1251734", "ISSN": ["0032-0943", "1439-0221"], "issn-type": [{"value": "0032-0943", "type": "print"}, {"value": "1439-0221", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T13:51:51Z", "timestamp": 1574689911615}, "reference-count": 0, "publisher": "Bentham Science Publishers Ltd.", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["TOPROCJ"], "published-print": {"date-parts": [[2013, 3, 1]]}, "DOI": "10.2174/2210289201304010207", "type": "journal-article", "created": {"date-parts": [[2015, 4, 14]], "date-time": "2015-04-14T09:23:23Z", "timestamp": 1429003403000}, "page": "207-207", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Flavonoid Analogues Isolated from the Stem Bark of Malaysian VAR. (Annonaceae) with Anticancer Properties"], "prefix": "10.2174", "volume": "4", "author": [{"given": "Nurunajah Ab", "family": "Ghani", "sequence": "first", "affiliation": []}, {"given": "Norizan", "family": "Ahmat", "sequence": "additional", "affiliation": []}, {"given": "Nor Hadiani", "family": "Ismail", "sequence": "additional", "affiliation": []}, {"given": "Asmah", "family": "Alias", "sequence": "additional", "affiliation": []}, {"given": "Nik", "family": "Khairunissa", "sequence": "additional", "affiliation": []}, {"given": "Nik Abdullah", "family": "Zawawi", "sequence": "additional", "affiliation": []}, {"given": "Siti Khadijah", "family": "Sulaiman", "sequence": "additional", "affiliation": []}], "member": "965", "container-title": ["The Open Conference Proceedings Journal"], "language": "en", "deposited": {"date-parts": [[2015, 4, 14]], "date-time": "2015-04-14T09:23:23Z", "timestamp": 1429003403000}, "score": 16.418898, "issued": {"date-parts": [[2013, 3, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2013, 3, 1]]}, "issue": "1"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/2210289201304010207", "ISSN": ["2210-2892"], "issn-type": [{"value": "2210-2892", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T11:36:51Z", "timestamp": 1574336211870}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drugs"], "published-print": {"date-parts": [[1994, 2]]}, "DOI": "10.2165/00003495-199447020-00006", "type": "journal-article", "created": {"date-parts": [[2007, 12, 5]], "date-time": "2007-12-05T11:08:43Z", "timestamp": 1196852923000}, "page": "305-317", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Antacids"], "prefix": "10.1007", "volume": "47", "author": [{"given": "Chi-Kong", "family": "Ching", "sequence": "first", "affiliation": []}, {"given": "Shiu-Kum", "family": "Lam", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Drugs"], "language": "en", "deposited": {"date-parts": [[2013, 1, 20]], "date-time": "2013-01-20T14:55:32Z", "timestamp": 1358693732000}, "score": 16.400639, "subtitle": ["Indications and Limitations"], "issued": {"date-parts": [[1994, 2]]}, "references-count": 0, "journal-issue": {"issue": "2"}, "URL": "http://dx.doi.org/10.2165/00003495-199447020-00006", "ISSN": ["0012-6667"], "issn-type": [{"value": "0012-6667", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}